NCT07142850View on ClinicalTrials.gov

A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HRS-9190 in Healthy Adults

PHASE1RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Skeletal Muscle Relaxation

Interventions

DRUG

HRS-9190

HRS-9190

Trial Locations (1)

410013

RECRUITING

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY